wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

MicroS03LQ3 - Orthomyxoviridae (Part 2)

Total questions: 31

Worksheet time: 17mins

Name
Class
Date
1.

(Physical Characteristics)


1. Withstands slow drying at room temperature on articles → Demonstrated in dust after an interval of 2 weeks


2. Survives for _________ at 4°C in infected tissue immersed in glycerol saline: (a) Survive in seawater; (b) Preserved for long periods at -70°C, & (c) Alkaline pH


3. Inactivated when exposed to heat for 30 mins at 56°C → By 20% ether in cold, phenol, formaldehyde, salts of heavy metals, detergents, soaps, halogens


4.Lipid solvents, protein denaturants, formaldehyde, and

irradiation destroy infectivity → acid pH


5. Both infectivity and hemagglutination → more resistant to inactivation at alkaline pH than at acid pH

a)

Days

b)

Weeks

c)

Months

d)

Years

2.

(Epidemiology)


This type of influenza virus produces the most common outbreaks & can sweep across continents and around the world in massive epidemics called pandemics

a)

A

b)

B

c)

C

3.

(Epidemiology)


This type of influenza virus has less extensive and less severe outbreaks & sometimes causes epidemics

a)

A

b)

B

c)

C

4.

(Epidemiology)


This type of influenza virus is the least significant & causes mild sporadic respiratory disease but not epidemic influenza

a)

A

b)

B

c)

C

5.

(Epidemiology)


Evidence supports the model that _______ serve as mixing vessels for reassortants because their cells contain receptors recognized by both human and avian viruses

a)

Pigs

b)

Rats

c)

Cows

d)

Dogs

6.

(Transmission)


Which of the following is/are mode of transmission of orthomyxoviridae?

a)

Inhalation of small aerosol droplets

(Visual-laden respiratory droplets when coughing and sneezing)

b)

Contact with contaminated hands or surfaces

c)

Confined populations like in nursing homes, classrooms, ships

d)

Low humidity and cool temperatures (DRY & COLD)

7.

(Pathogenesis)


Virus can establish infection of URT/LRT by compromising the mucociliary defenses of the respiratory tract

a)

True

b)

False

8.

(Pathogenesis)


Having systemic symptoms are due to ______ & lymphokine response, especially _____ since influenza viruses are sensitive to its antiviral effects


Infectious virus is also rarely recovered from blood

a)

Interferon

b)

Macrophages

c)

Compliment System

d)

Innate

9.

(Pathogenesis)


Innate immunity response contributes to host recovery from infection while specific antibody and cell-mediated immune responses cannot be detected for another 1-2 weeks

a)

True

b)

False

10.

(Pathogenesis)


___________: epithelial cell damage → ciliated and mucus secreting cells

(1) Causes cellular destruction and desquamation of superficial mucosa of the respiratory tract

(2) Does not affect the basal layer of epithelium

(3) Complete reparation of cellular damage takes up to 1 month → Leads to edema and mononuclear infiltrations

a)

Local symptoms

b)

Systemic symptoms

11.

(Pathogenesis)


Infected individuals predisposed to ______ superinfection because of loss of natural barriers and induction of bacterial adhesion to epithelial cells

a)

Bacterial

b)

Viral

c)

Fungal

d)

Parasitical

12.

(Immunopathology)


Interferon and cell-mediated immune response (NK and T cell) are important for both immune resolution and

immunopathogenesis

a)

True

b)

False

13.

(Immunopathology)


_______ of influenza A can undergo major and minor antigenic changes to ensure the presence of immunologically naïve and susceptible individuals

a)

HA & NA

b)

HA & NP

c)

NP & NA

14.

(Immunopathology)


A few cells of respiratory epithelium are infected if deposited virus particles did the following:

a)

Avoid removal by coughing

b)

Escape neutralization by preexisting specific IgA antibodies

c)

Avoid inactivation by nonspecific inhibitors in the mucous

secretions

15.

(Immunopathology)


__________ are soon produced which spread to adjacent cells where the replicative cycle is repeated which results to many cells in the RT become infected and killed eventually

a)

Progeny virions

b)

Toxic metabolites

c)

Genetic rearrangement

16.

(Course of the disease)


Incubation period: ______ and it depends on size of the viral dose and immune status of the host

a)

1 - 4 days

b)

4 - 7 days

c)

7 - 10 days

d)

10 - 12 days

17.

(Course of the disease)


Viral shedding starts the day preceding onset of symptoms and peaks within 24 hours or (3 to 4 days post-infection [Murray 8th ed])


It remains elevated for 1-2 days and declines over the next 5 days

a)

True

b)

False

18.

(Clinical manifestations)


(1) Incubation period: 1-4 days (average of 2 days)


(2) Adults: fever, malaise, headache, myalgia, anorexia, sore throat, dry cough


(3) Children: higher fever, GI symptoms (abdominal pain, vomiting), otitis media, myositis, croup

a)

Influenza A

b)

Influenza B

c)

Influenza C

19.

(Clinical manifestations)


(1) Milder 3 day febrile illness with predominantly systemic symptoms


(2) More GIT involvement “gastric flu”

a)

Influenza A

b)

Influenza B

c)

Influenza C

20.

(Clinical manifestations)


(1) Afebrile URTI

(2) Confined to young children

a)

Influenza A

b)

Influenza B

c)

Influenza C

21.

(Clinical manifestations)


Which of the following are the complications of orthomyxoviruses?

a)

Primary influenza pneumonia

b)

Bacterial pneumonia

c)

Myositis and cardiac involvement

d)

Neurological syndromes

22.

(Clinical manifestations)


Which of the following are example of neurological complications of orthomyxoviruses?

a)

Guillain-Barre Syndrome

b)

Encephalopathy

c)

Encephalitis

d)

Reye’s syndrome

23.

(Clinical manifestations)


An acute encephalopathy of children and adolescents, usually between 2 and 16 years of age


(1) Mortality rate is high (10-40%)

(2) Cause is unknown but it is recognized rare complication of influenza A and B, and VZV infections

(3) Epidemiologic relationship between salicylate use and subsequent development of this disease

a)

Reye's syndrome

b)

Guillain-Barre syndrome

c)

Encephalitis

d)

Encephalopathy

24.

(Clinical manifestations)


Timeline of classic/uncomplicated Influenza


Fever and systemic symptoms: last 3-5 days

__________ : last another 3-4 days

Cough and weakness: may persist for 2-4 weeks after major symptoms subside

a)

Respiratory symptoms

b)

Gastrointestinal symptoms

c)

Cardiac symptoms

25.

(Clinical Manifestations)


Pneumonia complicating influenza infections can be viral, secondary bacterial, or a combination of the two. Which of the following are bacterial pathogens that's commonly involved?

a)

S. aureus

b)

S. pneumoniae

c)

H. influenzae

d)

N. meningitidis

26.

(Clinical Manifestations)


_________ is a risk factor for lethal pulmonary complications in some epidemics

a)

Age

b)

Gender

c)

Work setting

d)

Pregnancy

27.

(Immunity)


The three types of influenza viruses are antigenically

unrelated, therefore induce no cross-protection for each types (A, B, C)

a)

True

b)

False

28.

(Immunity)


Antibody (including vaccine-induced Ab) can prevent disease. This Ab can protect the person against reinfection

a)

Ab to HA

b)

Ab to NA

c)

Ab to NP

29.

(Immunity)


Antibody (including vaccine-induced Ab) can prevent disease. This Ab can decreased severity of disease and decreased ability to transmit virus to contacts

a)

Ab to HA

b)

Ab to NA

c)

Ab to NP

30.

(Immunity)


IgA, serum IgG, and cell-mediated immunity (CMI) are

important. Which of the following are the primary roles of cell-mediated immune response?

a)

Clears established infection

b)

Cytotoxic T-cells lyse infected cells

c)

Cross-reactive (able to lyse cells infected with any subtype of the virus)

d)

Directed against internal proteins (NP, M) and surface

glycoproteins

31.

(Immunity)


A phenomenon where subsequent infections or immunization reinforce the Ab response to the first subtype of influenza experiences years earlier

a)

Original Antigenic Sin

b)

Original Antigenic Shift

c)

Original Antigenic Drift

d)

Cross Original Antigenic Sin